Latham & Watkins LLP Advises Baird Capital and Endeavour Vision on Virtual Incision Corporation’s US$46 Million Funding Round

Firm represented the two lead investors in the financing of the company reimagining robotically-assisted surgery.

December 02, 2021

Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery, has announced it has raised US$46 million in a Series C funding round. The round was led by Baird Capital and Endeavour Vision, with participation from returning investor Bluestem Capital and others. 

Latham & Watkins LLP represented Baird Capital and Endeavour Vision in the financing with a corporate deal team led by Boston partners Hans Brigham and Evan Smith, with New York associate Teddy Ellison.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.